<DOC>
	<DOCNO>NCT02090530</DOCNO>
	<brief_summary>Precision Cancer Medicine Advanced Cancer Through High-throughput Sequencing</brief_summary>
	<brief_title>Precision Cancer Medicine Advanced Cancer Through High-throughput Sequencing</brief_title>
	<detailed_description>This study support collection tumor specimens CLIA-certified genomic test research test parallel . CLIA-certified test establish measurement accuracy precision allow return result . This study involve treatment , test , could use meet eligibility criterion trial .</detailed_description>
	<criteria>1 . A histologically cytologically confirm diagnosis cancer 2 . Patients malignancy . 3 . Patients must tumor suitable research tumor biopsy ( assess train specialist interventional radiology ) Patients medically fit undergo tissue biopsy surgical procedure get tumor tissue OR If Patients tumor suitable biopsy another tissue available molecular evaluation . OR Patients undergoing standard care surgeries procedure fresh specimen first use routine pathologic assessment leftover tissue use research purpose . 4 . Procedurespecific sign informed consent prior initiation studyrelated procedure . 5 . Women minority include protocol . 6 . Patients multiple malignancy remain eligible . 7 . Patients inherited cancer syndrome medical history suggestive inherited cancer syndrome remain eligible . 1 . It enrol study physician discretion decide patient fit enough undergo tissue biopsy . 2 . Patients incarcerate eligible participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cancer Genomics</keyword>
	<keyword>Tumor Sequencing</keyword>
</DOC>